v3.26.1
Segment Information (Details)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2026
USD ($)
Mar. 31, 2026
USD ($)
Jun. 30, 2025
USD ($)
Mar. 31, 2025
USD ($)
Jun. 30, 2026
USD ($)
segment
Jun. 30, 2025
USD ($)
Segment Reporting [Abstract]            
Number of reportable segments | segment         1  
Segment Reporting [Line Items]            
Interest income $ 277   $ 850   $ 710 $ 1,847
Interest expense (475)   (1,301)   (1,843) (2,564)
Loss on extinguishment of note payable (3,354)   0   (3,354) 0
Other income, net 64   11   738 179
Net income (loss) 3,670 $ (13,532) (17,982) $ (18,089) (9,862) (36,071)
Reportable Segment            
Segment Reporting [Line Items]            
Collaboration revenue 21,000   0   21,000 0
General and administrative support 6,678   3,486   11,250 7,309
Clinical development 3,047   5,710   6,690 10,039
Research and discovery 1,028   3,537   3,183 6,856
Manufacturing 218   2,610   1,792 6,698
Other segment expenses 2,871   2,199   4,198 4,631
Interest income 277   850   710 1,847
Interest expense (475)   (1,301)   (1,843) (2,564)
Loss on extinguishment of note payable (3,354)   0   (3,354) 0
Other income, net 64   11   738 179
Net income (loss) $ 3,670   $ (17,982)   $ (9,862) $ (36,071)